Detalhe da pesquisa
1.
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
Neurol Sci
; 43(3): 2031-2041, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424427
2.
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
Oncologist
; 26(12): 1079-1084, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355463
3.
Survival in Patients With Sentinel Node-Positive Melanoma With Extranodal Extension.
J Natl Compr Canc Netw
; 19(10): 1165-1173, 2021 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34311443
4.
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
J Transl Med
; 12: 116, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885479
5.
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program.
Cancer Invest
; 32(4): 144-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24484235
6.
Fertility preservation for patients with melanoma.
Melanoma Res
; 32(5): 303-308, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35855660
7.
Immune-related Bell's palsy in melanoma patients treated with immune checkpoint inhibitors.
Melanoma Res
; 31(2): 178-180, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33492050
8.
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
Target Oncol
; 16(4): 529-536, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076798
9.
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience.
J Gynecol Oncol
; 30(6): e94, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31576688
10.
Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic Melanoma.
Am J Clin Oncol
; 42(8): 643-648, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31261257
11.
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience.
Melanoma Res
; 29(3): 289-294, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520799
12.
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma.
J Cancer Res Clin Oncol
; 145(2): 511-521, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30539281
13.
Developing a score system to predict therapeutic outcomes to anti-PD-1 immunotherapy in metastatic melanoma.
Tumori
; 105(6): 465-473, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446882
14.
Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis.
Oncol Res Treat
; 42(4): 186-194, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836373
15.
Current status and perspectives in immunotherapy for metastatic melanoma.
Oncotarget
; 9(15): 12452-12470, 2018 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29552325
16.
Unusual Skin Carcinomas Induced by BRAF Inhibitor for Metastatic Melanoma: A Case Report.
J Clin Diagn Res
; 11(7): XD06-XD08, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893027
17.
Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experience.
Tumori
; 102(5): 501-507, 2016 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470608
18.
Immunology of cancer stem cells in solid tumours. A review.
Eur J Cancer
; 50(3): 649-55, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24333096
19.
A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma.
Oncoimmunology
; 3(11): e963406, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25941591
20.
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.
Can J Ophthalmol
; 50(1): e2-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25677296